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Abstract: Pain and injuries are inevitable occupational hazards and health risks in athletes’ 
working lives. The sport-related use of analgesics with and without injury is widespread. 
Taking analgesics to compete while injured is conceptualised as a sickness presenteeism 
problem. This study examines the complexity of the sport-related use of analgesics in elite 
sport. A mixed-method design was adopted consisting of a survey (n=775) and interviews 
(n=21) with elite athletes. Many athletes reported a sport-related use of analgesics. Analgesics 
had commonly been used to enable an injured athlete to: compete in an important match; train 
during an important period; qualify for an important match/final; and keep one’s position on 
the team or have one’s contract prolonged. In particular, team-sport athletes had experience 
of such use. Apart from the therapeutic use of analgesics, they were sometimes integrated into 
different routines: for example, enhancing performance, avoid lowering performance, aiding 
recovery, training/competing injured and prophylactic use. Simultaneously, many had 
refrained from using or sought to minimise their sport-related use of analgesics; reasons were 
related to: trust in/feeling the body, side-effects, knowledge and social norms. Social norms 
and interaction with support personnel played a key role. Physiotherapists and doctors often 
advised athletes on analgesics, but self-administered use was widespread. How risk cultures 
manifested themselves varied greatly between sports, and gender differences were scarce. 
Although ‘absenteeism’ is also present, a majority of athletes would be willing to ‘walk the 
line’, using analgesics to compete when injuries may threaten their career or sporting success. 
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1. Introduction   
Pain and injuries are inevitable occupational hazards and health risks in the working lives of athletes 
(Beamish and Ritchie, 2006). The prevalence of injuries is high across a range of sports (Ristolainen et al. 
2012). Frequent or severe injuries pose a threat to athletes’ careers and can affect occupational health and 
wellbeing: for example, injuries can be associated with a painful rehabilitation process and create 
uncertainty about the future (Thing, 2006); affect results and ranking (Roosen and Heijne, 2018); lead to 
early or involuntary termination of a sporting career (Ristolainen et al., 2012); cause a permanent disability 
(Turner et al., 2000); and harm mental health and wellbeing during a sporting career (Roderick, 2006; 
Wiese-Bjornstal, 2010) as well as after the career has ended (Gouttebarge et al., 2015).  
Concurrently, there is a high prevalence of the sport-related use of analgesics across a range of sports 
(Alaranta et al., 2006; Tscholl et al., 2015), particularly non-steroidal anti-inflammatory drugs (NSAIDs). 
Training or competing with injuries often involves the use of analgesic medicines or injections, but the 
prophylactic use of analgesics is also common (Warden, 2009) in endurance events (Joslin et al., 2013) and 
team sports (Tscholl et al., 2015). Analgesics are an integral part of pain management in sport (Hainline et 
al., 2017) as a self-administered therapy and/or under supervision. Increase in pain tolerance due to the use 
of analgesics may explain a slight effect on endurance performance parameters and aspects of 
neuromuscular performance (Lundberg and Howatson, 2018). The general effects of analgesics depend on 
the type, on the dosage and whether poly-drug use is involved. The products cover, for example: non-
steroidal anti-inflammatory effects and pain relief (NSAIDs, e.g. ibuprofen), steroidal anti-inflammatory 
and metabolic effects and pain relieve (e.g. glucocorticoids), and non- NSAIDs with mild (e.g. 
paracetamol) to moderate or strong pain relief (opioids, e.g. tramadol).  
The prophylactic (Warden, 2009) and therapeutic (Alaranta et al., 2006) use of NSAIDs may lead to 
acute side-effects (e.g. potentially severe side-effects in the gastrointestinal tract and kidneys). The use of 
cortisone can have serious short- and long-term side-effects (Vernec et al., 2019). Despite some evidence 
of the positive effect of NSAID use after acute muscle injury (Morelli et al., 2018) the benefits of NSAID 
treatment on muscle repair after injury might be outweighed by the costs, i.e. potentially long-term negative 
effects, for example on muscle recovery (Mackey et al., 2012).  
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The use of analgesics has negative impacts on some athletes even after the end of their sporting career. For 
example, retired athletes’ current (mis)use of analgesics has been linked to issues arising during their 
sporting career, for example the misuse of opioids (Cottler et al., 2011) and the alleviation of pain and 
inflammation associated with football injuries (Sanders and Stevinson, 2017). Most of the commonly used 
analgesics are permitted in sport. Tramadol has recently been prohibited in cycling. Sport-related uses of 
glucocorticoids (cortisone) are widespread (Vernec et al., 2019). Glucocorticoids are prohibited in sport 
only in competitions by ‘systemic’ (oral, rectal, intramuscular or intravenous) routes, but per- mitted via 
local administration (e.g. intra-articular injections) and used as treatment for several conditions, including 
injuries, and sometimes (mis)used in the absence of a medical condition.  
1.1 Culture of risk and precarious working conditions  
Embedded in elite sports is a normalised ‘culture of risk’ (Bette, 2004) in which competing hurt, the 
expectation of always striving for success and accepting health risks are internalised by athletes, coaches 
and sports medicine specialists (Andersen and Jackson, 2013; Roderick, 2006). Sporting careers are often 
short-lived, insecure and uncertain (Roderick, 2006) with a significantly higher risk of injury and 
dependence on the body’s functionality compared with most other occupations (Bette, 2004). Thus, injured 
athletes face time pressures to play hurt or return to sport too quickly. Athletes’ strong commitment and 
striving for success often leads to them playing while injured, which in turn increases the impairment and 
thus eventually reduces the chance of obtaining sporting success – the ‘risk-pain-injury paradox’ (Nixon, 
1996). A recent study has added a new dimension to these issues when conceptualising the phenomenon 
of playing hurt as a sport-specific ‘sickness presenteeism’ problem (Mayer and Thiel, 2018). From this 
perspective, accepting (or ignoring) health risks and training or competing when injured can be considered 
as work presenteeism, i.e., working while ill or injured (Johns, 2010; Mayer and Thiel, 2018), and the use 
of analgesics may become a tool in this endeavour.  
In the working context of sport, athletes who do not comply with sickness presenteeism, for example, 
are unwilling to ‘play hurt’ (using analgesics) risk being stigmatised, isolated and ignored by managers 
(Roderick, 2006; Law and Bloyce, 2019). Coaches and medical staff play a pivotal role in decisions 
whether to compete while injured (Mayer and Thiel, 2018). Medical personnel are faced with dual roles 
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and pressures and must negotiate between restoring athletes’ health while simultaneously assisting in 
enhancing performance levels (Andersen and Jackson, 2013; Safai, 2003). This is an interaction that 
occasionally relates medical advice to lack of care for the injured athlete’s health (Waddington and 
Roderick, 2002), breaches in athlete-patient confidentiality (Malcolm and Scott, 2014) and often results in 
a too early return to sport and in the use of analgesics to be able to do so (Waddington and Roderick, 2002).  
Studies suggest that male and female athletes from different countries internalise the ‘culture of risk’ 
to a similar degree (Nixon, 1996; Charlesworth and Young, 2006). Accordingly, several studies report a 
gender difference neither in the prevalence of the use of NSAIDs (Alaranta et al, 2006; Tscholl et al., 2015) 
nor in their willingness to compete hurt (Mayer and Thiel, 2018; Mayer et al., 2018).  
On the other hand, how the risk culture manifests itself varies greatly between sports disciplines 
(Mayer and Thiel, 2018; Schnell et al., 2014). Sports disciplines also vary in their injury risk profiles 
(Hägglund et al., 2016) and in the use of NSAIDs (Alaranta et al., 2006).  
1.2 Sport as an exceptional and risky occupation: the sport-related use of analgesics and 
presenteeism  
Drawing on Rhodes’ (2009) risk environment framework (while integrating concepts from figurational 
sociology), it has been argued that elite sport constitutes a unique social practice comprising an exceptional 
and risky working environment in which some unique features – interactions and interdependencies 
between individuals and environments – foster specific risk environments and occupational risks that differ 
from other working contexts (Overbye, 2018). Some of these features involve specific working conditions 
and demands on athletes, some of which concur with risk factors associated with sickness presenteeism 
(e.g. job insecurity, time pressure, little replaceability, treating the working environment as home and being 
over-committed to work, Hansen and Andersen, 2008). Specific working conditions and interdependencies 
help to understand an increased sport-work related use of pain-relieving medicines and how multiple actors 
impact on both harm production and the reduction of drug use in this regard (Overbye, 2018). Athletes are 
socialised into the working context of sport and drug use (Ohl et al., 2015), which implies striving for 
performance enhancement and accepting health risks (Section 1.1). The pivotal role of the body’s 
functionality to do the job becomes the Achilles heel (Bette, 2004). In this context (sickness) presenteeism 
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(Johns, 2010; Section 1.1) involving analgesics may become a socially encouraged practice – although 
absenteeism is also present. Sport-related drug use (including analgesics) is expected and can be 
understood as coping with the specific working context (Overbye, 2018). Apart from the “normal” 
therapeutic use of analgesics (e.g. injury treatment or operation), they may be used to cope with career 
obstacles such as injuries (Tscholl et al., 2015) or selection-related stressors (Didymus and Backhouse, 
2020); to enhance performance or avoid lower performance due to pain or small injuries; and also as a 
prophylactic. Importantly, considering the different definitions of presenteeism (Johns, 2010:521) different 
types of the sport-related use of analgesics may also constitute forms of presenteeism, for example, 
involving running health risks to attend work.1  
1.3 Aims of the study   
Mayer and Thiel (2018) highlight the significance of not only the structure of the working context but also 
personal and organisational expectations with regard to absenteeism or presenteeism, thus suggesting that 
advice on, and the sport-related use of, analgesics varies greatly within sporting contexts and during an 
athlete’s career. Moreover, Dunn (2015) emphasises the importance of understanding the prevalence and 
the motivations for the use of pain-relieving prescription medicines in sport.  
The research field related to sickness presenteeism has been dominated by qualitative studies. 
Exceptions to this are recent German quantitative studies (Mayer and Thiel, 2018; Mayer et al., 2018; 
Schnell et al., 2014). Further, knowledge about athletes’ use of analgesics to be able to train and compete 
when injured is scarce. Mayer and Thiel (2018) and Mayer et al. (2018) have integrated one item measuring 
whether athletes would find it legitimate or would refuse to compete if they had to take painkillers to do 
so. These studies provide novel insights into sickness presenteeism among German elite handball and 
track-and-field athletes, and characteristics of elite sport subcultures affecting German adolescent elite 
athletes’ willingness to compete hurt. 
Yet we lack knowledge of not only situational aspects such as which situations motivate to use of 
analgesics in and out-of-competition but also why some athletes – even within cultures of risk, in which 
analgesics is standard practice – refrain from using painkillers. Knowledge is also scarce concerning the 
complexity of the sport-related use of analgesics such as for performance enhancement, recovery and 
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prophylactic use. No studies have (so far) explored a larger group of elite athletes’ approaches to the sport-
related use of analgesics – with and without injuries – and their thoughts on use and guidance applying a 
mixed-method design. Further, although differences have been identified between sports, we still lack 
knowledge about sport-specific issues and whether gender specific patterns exist.  
To fill this gap, the current study applies a mixed-method design and sets out to investigate the 
following research questions: firstly, how large is the proportion of Danish elite athletes who have used 
analgesics in connection with their sport? (RQ1); secondly, why and when have athletes engaged in a sport-
related use of analgesics? And how do different situations and circumstances affect athletes’ willingness 
to use analgesics in sport? (RQ2); thirdly, do athletes seek to refrain from or minimise the use of 
analgesics? And what are the reasons for refraining from analgesics? (RQ3); fourthly, who supervises 
athletes’ use of analgesics? What role can the sporting/training environment play in the use of analgesics? 
How do athletes approach guidance and the self-administration of analgesics? (RQ4); And, fifthly, how do 
athletes of different genders and sports differ in their approaches to analgesics? (RQ5).  
2. Material and methods  
2.1 Procedure and participants  
A web-based questionnaire was distributed by email to all of the Danish elite athletes supported by the 
national elite organisation Team Danmark (69.5%) and to additional national team athletes from sports 
federations/teams not included in Team Danmark’s support programme (30.5%). A total of 775 athletes 
completed the questionnaire (response rate: 51%), of whom 41% were female and 59% male athletes with 
a mean age of 22 years. A total of 696 athletes answered the survey questions on analgesics. Forty sports 
were represented and grouped into Team Sports (47%) and Individual Sports (53%). Among the athletes 
supported by Team Danmark 14% were categorised (by Team Danmark) as “world-class athletes” (ranked 
eighth or better at the world championship or Olympic Games); 26% were “elite athletes” (national senior 
team athletes); and 61% were “Team Danmark athletes” (mostly elite athletes on the periphery of a senior 
national team and upcoming talents selected for national junior team squads). The athletes not supported 
by Team Danmark were national senior or junior team athletes of a high competition level. The qualitative 
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part consisted of semi-structured face-to-face interviews (n=21) and open-ended answers in the 
questionnaire (n=63). The inclusion criteria for interviews were: high performance level (had a competition 
level that qualified them for one of Team Danmark’s support categories or national federation selection at 
some point), sport (swimming, cycling, badminton) and gender (equal representation). Almost all of the 
athletes invited for interviews accepted the invitation. The sports represented were: swimming (female 
n=4; male n=4), badminton (female n=4; male n=4) and cycling (female n=2; male n=3). The age range 
was between 20 and 32 years. The researcher is a former elite athlete and the (former) “insider” status 
could influence the research process.  
2.2 Measures  
A multi-dimensional mixed-method design was adopted (Mason, 2006). This is useful because the mixing 
and linking of methods (questionnaire and different forms of qualitative data) and theoretical 
approaches/concepts (Sections 1.1,1.2) relating to themes (“knots”, i.e. multiple perspectives around the 
use of analgesics in the working context of sport) provide “multi-nodal” explanations that can enhance our 
understanding of the sport-related use of analgesics and allow for more comprehensive answers to the 
research questions.  
Questions on analgesics were integrated into a questionnaire assessing elite sport life and elite 
athletes’ views on and experience with legal performance-enhancing drugs and methods (author, 2013). 
The survey items on analgesics were developed mainly with inspiration from findings in interviews with 
current and former elite athletes from different sports and existing research in the area (e.g. Roderick, 
2006). This qualitatively driven design (Mason, 2006) allows for new (as yet unexplored) quantitative 
perspectives on the use of analgesics. The questions referred to: Q1: the sport-related use of different types 
of analgesics (4 items); Q2: reasons for using analgesics (11 items); Q3a: willingness to use analgesics in 
specific situations among athletes who had not yet used them in the given situation and Q3b: among 
athletes who had never used analgesics in a sporting context (up to 6 items); Q4a: whether athletes refrain 
from or minimise the use of analgesics (4 items); Q4b: reasons for refraining from or minimising the use 
of analgesics (13 items); and Q5: guidance on analgesics (7 items). (See figures and tables for items and 
scales).  
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The qualitative part of this study consisted firstly of open-ended questions in the survey provided in 
Q2-Q5 to allow participants to elaborate on their answers and an inductive development of themes. 
Secondly, questions about analgesics were integrated into interview-guidelines developed to gain in-depth 
knowledge of the elite athletes’ lives, including their working conditions and approaches to performance-
enhancing strategies in sport (author, 2013). The questions about analgesics were integrated into two areas 
of the interview-guidelines. Firstly, questions explored the athletes’ experiences with and perceptions of 
the sport-related use of analgesics. The interviews also inquired into the roles of the coaches and other 
experts for the athletes’ sporting lives and practices. Secondly, the interview-guidelines included a 
discussion-scheme – designed to explore social norms related to performance enhancement. The sport-
related use of, respectively, mild pain relief, NSAIDs and cortisone was included (as three out of 24 
performance-enhancing strategies in the discussion-scheme) and discussed based on the athletes’ own 
practice and/or sporting environment.  
2.3 Data analysis 
The data was analysed using SPSS 23. Descriptive data are reported as frequencies and percentages. Bi- 
and multivariate nonparametric statistics were used to compare differences and associations between 
groups of athletes with regard to gender and sport type. Differences were assessed using a chi-square and 
gamma test, odds ratio risk estimates.  
All the qualitative accounts from open-ended answers in Q2-Q5 were all read in-depth – analysed 
inductively and grouped inductively into themes – and then displayed in a table within each question (Q2-
Q5) with illustrative quotes within each theme. The interviews were all carried out and transcribed fully 
by the author. The transcriptions were read in-depth, and areas and narratives about analgesics and injuries 
were identified. Inductive and deductive reasoning were combined, and thematic coding was performed to 
identify topics and narratives. The analytic generalisation strategy was inspired by category zooming 
(Halkier, 2011). This approach can be useful when contradictions, exceptions and processes cannot easily 
be identified as ideal types and it is relevant to zoom in on single aspects (or categories) in data placed in 
context. Based on the data, some similarities on a more general level were identified (e.g. almost all had 
experiences with sport-related use of analgesics). Simultaneously, data showed that zooming in on how it 
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was used, particularly “sport-specific issues, gender and meanings of sport-related use” and “issues of 
guidance, influencers and self-administration of use” would be relevant; and three perspectives are 
provided (contributing knowledge to the research questions 2-5) in Section 3.6.  
3. Results  
With regard to the participants’ characteristics, most of the 696 athletes replying to the questions on 
analgesics had had long-lasting injures (68%), and 17% had had one or more operations due to overload 
or acute injury (Table 1).  
>>Table 1<< 
 
3.1 What is athletes’ experience with sport-related use analgesics?  
Almost all athletes (93%) had experience with sport-related pain-relieving products. Half (49%) of the 
athletes had used NSAIDs in a sporting context several times, and 18% had had local cortisone injections 
at least once (Figure 1).  
>>Figure 1<< 
Using bivariate distributions, differences between groups of athletes were revealed in their sport-related 
use of analgesics. Female athletes from individual sports were more likely to have used mild pain relief 
products compared to male athletes from individual sports (87% vs. 74%)(OR 2.42(1.36;4.31);gamma-
value:0.42; p<0.001), while male team-sport athletes were more likely to have used NSAIDs compared to 
female team-sport athletes (66% vs. 54%)(OR 1.66(1.05;2.62);gamma-value:0.25; p<0.037). 
3.2 What are the reasons for sport-related use of analgesics? 
The athletes (93%, n=631) who had experience of pain-relieving products were asked about their reasons 
for this sport-related use. The most common reasons were to relieve headaches (82%) and to be able to 
compete in an important match despite an injury (64%). The least frequent reasons were use as an integral 





Differences were found between groups of athletes in their reasons for having used analgesics. Team-sport 
athletes more frequently reported to have used analgesics while injured to be able: to compete in an 
important match/competition (72% vs. 57%)(OR 1.95(1.39;2.72);gamma-value:0.32; p<0.000); to train or 
compete to keep their position on the team or have their contract prolonged (35% vs. 22%)(OR 
1.93(1.35;2.74);gamma-value:0.32; p<0.00); to compete to qualify for an important match or final (65% 
vs. 35%)(OR 3.47(2.50;4.82);gamma-value:0.55; p<0.00); and to relieve soreness (67% vs. 53%)(OR 
1.78(1.29;2.47);gamma-value:0.28; p<0.00). Adjusting for gender showed that female individual athletes 
were more likely than male individual athletes to have taken analgesics to compete in an important 
competition while injured (62% vs. 54%)(OR 1.63(1.04;2.56);gamma-value:0.24, p<0.032) whereas male 
team-sport athletes were more likely than female team-sport athletes to have taken analgesics while injured 
to compete in an important competition (78% vs. 64%)(OR 1.99(1,20;3.33);gamma-value:0.332; p<0.008) 
and to qualify for an important match/final (71% vs. 58%)(OR 1.74(1.08;2.80);gamma-value:0.27; 
p<0.028). Female athletes reported more frequently on the sport-related use of analgesics to relieve a 
headache (92% vs. 75%)(OR 3.72(2.36;6,11);gamma-value:0.58; p<0.00).  
3.3 How do specific situations affect athletes’ willingness to use analgesics? 
To identify whether reasons for not having used analgesics in specific situations were due to a lack of 
willingness to use pain-relieving products in this particular situation or if the athlete had not yet been in a 
given situation that required its use, all of the athletes who had not already used pain-relieving products in 




A majority of the athletes had already used or would (perhaps) be willing to use painkillers in situations 
of injury: if this allowed them to compete despite an injury (84%) or if it was deemed necessary to qualify 
for an important match (78%). Using pain-relieving medicines solely for performance-enhancing reasons 
(43%) was less acceptable within the athlete group.  
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3.4 Do athletes refrain from or minimise the use of pain-relieving medicines? And if so, why?  
In total, 38% of the athletes reported that they had experienced situations in which they decided to refrain 
from or minimise a sport-related use of pain-relieving medicines. In contrast, 28% declared never to have 
consciously decided to refrain from or minimise the use of pain-relieving medicines, and 18% reported 
never to have been in a situation in which it was necessary to refrain from or minimise their use. A minority, 
15% did not know whether they had refrained from or minimised the use of pain-relieving medicines. 
Refraining from or minimising the use of analgesics was not significantly associated with gender or sport 
group (or any interactions between these groups) (n=691).   
Athletes who reported having experience of refraining from or minimising the use of analgesics (38%; 
n=265) were subsequently asked about their reasons for this decision. The reasons related to: i) trust 
in/feeling the body; ii) worries about physical and mental side effects; iii) lack of knowledge; and iv) social 
norms (Figure 4). The most frequent reasons were to be able to ‘feel the body’ (n=175; 25% of total) and 
trusting in the body’s ability to cope with the situation (n=154; 22% of total).  
 
>>Figure 4<< 
3.5 Who provides guidance on the sport-related use of analgesics?  
Only 7% (n=46) reported never to have received any guidance and never themselves to have searched for 
knowledge within the area of pain-relieving medicines. On average, athletes reported more than two 
sources of guidance (2.32 (SD=1.51)), physiotherapists being the most frequent source (57%). One third 
(34%) (also) self-administered pain-relieving medicines (Figure 5). In total, 52% self-administered use 




Differences emerged between groups of athletes in their sources of guidance. Individual sport athletes 
more frequently reported the coach or managers as their source of guidance for analgesics use (45% vs. 
31%)(OR 1.86(1.36;2.55);gamma-value:0.301; p<0.001); and were less likely to be guided by 
physiotherapists (49% vs. 68%)(OR 0.45(0.33;062);gamma-value:-0.379; p<0.001). Male athletes were 
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more likely to obtain knowledge and exchange experience with training mates or others (37% vs. 28%)(OR 
1.49(1.07;2.08);gamma-value:0.20; p<0.015) and to self-administer analgesics (38% vs. 28%)(OR 
1.61(1.56;2.24);gamma-value:0.23; p<0.004). However, when adjusting for sport, gender differences were 
only found between male and female team-sport athletes in exchanging knowledge in the training 
environment (41% vs. 23%)(OR 2.31(1.14;3.78);gamma-value:0.40; p<0.00) and between male and 
female athletes from individual sports in their self-administration (41% vs. 31%)(OR 
1.57(1.01;2.46);gamma-value:0.22; p<0.043). 
3.6 The sport-related use of analgesics, guidance and self-administration: A matter of sport, 
gender and the sporting environment/network?  
Qualitative data helps to obtain more comprehensive answers to the research questions RQ2-5 (Section 
2.2-2.3). This is done, firstly, by providing a more in-depth understanding of gender and sport-specific 
issues related to the complexity of elite athletes’ use of analgesic, including differences in the role of the 
sporting network/training environment and self-administration; and, secondly linking this with the 
quantitative data and concepts relating to the same research questions (Section 2.1-2.2), particularly in the 
discussion (Section 4).  
Table 2 provides an overview of the surveyed athletes’ elaborations on their considerations when 
using or refraining from using analgesics in a sporting context, their willingness to use them and guidance 
(n=63). It expands the knowledge in relation to Q2-5 by elaborating on specific situations, deliberations 
about use, considerations of health and personal routines.  
>>Table 2<< 
 
Almost all the athletes interviewed had experiences with analgesics in training or competition. However, 
the use was often described as a non-habitual practice. Athletes dissociated themselves from systematic 
use or use in certain situations. What the athletes (with experience of competing injured using analgesics) 
had judged in the past as a competition ‘important enough’ to legitimise the use of analgesics to be able to 
compete while injured often related to a sense that it was important for them to compete that particular 
time rather than what one might regard as an “important competition” (e.g. a World Championship). 
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Despite these similarities in experiences with and deliberations on the use of analgesics, the interviews 
illustrated some sport-specific patterns and issues in use of analgesics and in whether, how, when or which 
support personnel played a role in the use of analgesics (the athletes’ degree of autonomy varied 
considerably) and gender similarities. Perspectives (Section 2.3) within each sport are described below.  
3.6.1 The impact of sport socialisation on the use of analgesics in swimming. The ‘persuasive’ coach  
Occasionally, the guidance from sporting networks can be seen more as exerting pressure on athletes to 
use analgesics with and without an injury (Section 1.1; Table 2). Several of the swimmers interviewed 
were hesitant to use analgesics; sometimes this was described as an integral part of growing up. The 
coach’s persuasive argumentation, however, influenced many swimmers to follow his instructions – or 
some of them. Gender similarity in approaches to analgesics (and supplements) was prominent. However, 
family socialisation made the coach’s advice barrier-breaking. After the coach had realised that many of 
the swimmers would prefer not to take pills (in this case referring to both analgesics and new legal 
supplements), he sought to alter the athletes’ way of thinking. Below is a female athlete’s description of 
the coach’s arguments and how she took these into consideration:  
“Do you know that all of your competitors take all sorts of different supplements?” – not 
hinting at EPO or anything – but what one takes, and how we then could think of saying ‘we 
do not want this’ and then believe we could be as good as them?…And this I thought about, 
I felt it made sense – because I do not see myself as being better than my competitors – that I 
could do it without help! (female, swimming) 
In response the swimmer started using analgesics as part of a ‘recovery routine’ – although sometimes she 
would just tell the coach she had taken it. Not all athletes faced the same demand from the coach, but this 
difference in interaction with the coach can only partly explain the differences in reaction. These also 
depended on family and sport socialisation and the degree of autonomy offered. For example, a male 
swimmer was hesitant about taking medicine and refrained even from asthma medicines – despite having 
been granted permission to use these. He stressed that if the coach asked him to use analgesics to reduce 
muscle pain during competitions, he would require more information. Self-administration was seldom 
mentioned, but one female swimmer had adopted her own routine: she would occasionally – at home – use 
analgesics to relax the body to be able to sleep during hard training periods.  
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3.6.2 The sport-related use of analgesics and self-administration in the badminton environment 
In the badminton environment one athlete was mentioned by several players because he ‘walked the line’ 
for the sport and continuously used a variety of pills to be able to train and compete despite injuries. 
Although other players understood this athlete’s willingness to run risks and make sacrifices for the sport, 
the number of pills he took was considered too extensive. However, a female athlete explained that the use 
of ibuprofen was common (particular during competitions): the physiotherapist provided the pills, but 
many would also self-administer them. She had also competed on these herself, but only the “light ones” 
– pills she described as harmless and solely for the purpose of relieving pain, not removing it. The notion 
that pills like those containing ibuprofen were harmless because they still left the athlete with some pain – 
and thus a sense of bodily control – was also stressed by other athletes (also from other sports). In this 
context, some athletes would also use them during competitions to shift the focus from the pain or a minor 
injury to performing well. Some athletes would self-administer analgesics when they disagreed (or 
expected to disagree) with the physiotherapist’s advice or felt their recovery from injury was too slow.  
…this was in periods when I was in pain. Then I had to take some pills to train. And also if I 
had injuries and the physiotherapists’ (treatment) was not as quick as I thought it should be. 
Then I perhaps started on a course of ibuprofen treatment without them being involved. And, 
of course, I know one should not be training 100% when on pills, but I made sure, of course, 
to cut down a bit. But I did train. (female, badminton)  
The findings suggest that some female players’ practices concur with some of the men’s in this training 
environment. This contradicts a male athlete’s representation of gender differences who brought up the 
issue of virility when discussing analgesics and guidance in his sport, explaining that he would expect the 
“girls” to go to the physiotherapist (and follow his/her advice) – but “boys” would act differently:   
…for example, many of us boys just refrain from going to the physiotherapist if we know he 
would say, “It is stupid to go to this competition.” Then we would not consult him – because 
there isnʼt any reason to know this! We will just take a couple of pills instead, then itʼs okay. 
(male, badminton) 
There were, however, differences between individual players in their approaches to analgesics. 
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3.6.3 The in-competition use of analgesics in cycling, influencing sporting networks and self-
administration 
The cyclists interviewed varied greatly in their experiences of and approaches to the sport-related use of 
analgesics. Gender differences seemed dominant among the cyclists interviewed: the male cyclists were 
more experienced and open towards the sport-related use of analgesics than the female cyclists. However, 
the low number of interviews in cycling – and the fact that the cyclists interviewed were members of 
different teams and environments – suggests that no conclusions should be drawn about gender. 
Particularly cyclists mentioned in-competition use as a means of reducing pain (to enhance performance) 
along with prophylactic use. The male cyclists expected such use to be widespread: one cyclist describes 
how others could be inspired by “insiders” to “try it out” when hearing stories about other riders using 
them, for example of an extensive in-competition use of a well-known successful cyclist. This cyclist self-
administered their use and the doses himself. He tried only to do this during important competitions but 
found that it easily became part of the competition routine:   
It easily becomes something like, okay, there I was riding fast, and at that time I took 2-3 of 
these pills (aspirin). And then it is like you need to have it again to be able to ride fast. It is 
psychological somehow (male, cycling).   
For another male cyclist an “in-competition” routine with analgesics combined with caffeine was 
introduced by the staff in a new team. However, during the first years of his employment he was ‘lucky’ if 
he was given any, but this gradually changed. He now sought to reduce their use by avoiding to take them 
if ‘not necessary’ – as in the many races in which he was only in the peloton.  
Local cortisone injections are common (Figure 1). Some of the cyclists mentioned cases of cyclists 
being given cortisone in-competition for a ‘sore knee’ (‘simulating’ an injury).  
4. Discussion  
The study was designed to explore the complexity of the sport-related use of analgesics in the working 
context of sport, investigating in particular elite athletes’ experience of and willingness to take analgesics 
in order to train or compete despite injury, their use of analgesics for other reasons, as well as athletes’ 
approaches to their use, to sources of guidance and to self-administration.  
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The study applies a multi-dimensional mixed-method design (Sections 2.2-2.3,3.6). Data is linked and 
discussed under the following indicative headings: “Sport-related use of analgesics: “Walking the line?” 
(RQ: 1-3); “The social and cultural context of use of analgesics: ‘One for the team’?” (RQ: 2,4); “Sport-
related use of analgesics: A matter of gender?” (RQ: 2,5); “Normalisation: Just part of the routine in the 
sport?” (RQ: 2-5); “No pain, no gain – or feeling and ignoring body pain?” (RQ: 3,4); and “Guidance on 
analgesics or self-administration of use?” (RQ: 2,4,5).  
4.1 The sport-related use of analgesics: Walking the line? 
Sport is a precarious profession, and the basic characteristics of work in elite sport are formed from factors 
associated with work-related presenteeism and the corresponding expectations in the working environment 
(Section 1.2). In line with the findings of Mayer and Thiel (2018) many athletes showed indications of 
work-related presenteeism. In fact, the high proportion of athletes who had taken analgesics to train or 
compete while injured, as well as those who reported to be willing to do so in certain situations, and those 
who used analgesics for other purposes without injuries (Figure 2,3; Section 3.6) suggests that a majority 
of athletes would be willing to ‘walk the line’. This is particularly so in situations when injuries may 
threaten sporting success or an athlete’s career.  
The finding that almost all of the athletes had experience of a sport-related use of analgesics in 
different situations was expected, considering i) the high proportion of athletes who had had small or long-
lasting injuries and sport-related operations (Table 1); ii) the risk culture existing in sport, which may 
involve sickness presenteeism (Section 1.1-1.2); iii) the well-established in-competition use without 
injuries (Joslin et al., 2013); and iv) the known high prevalence of particularly NSAIDs across a variety of 
sports (Alaranta et al., 2006).  
Various types of the sport-related use of analgesics may be considered indications of work-related 
presenteeism (Section 1.2). The in-competition practices and routines involving the use of analgesics to 
enhance performance were adapted by some athletes (Figure 2, Section 3.6.1-3), however, considering the 
working conditions in sport (Section 1.1-1.2) one might expect even more athletes to have used analgesics 
to enhance performance without injuries. An explanation might be that some athletes would prefer to know 
that they (and not a drug) are responsible for a good performance (Overbye, 2013). Further, analgesics are 
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not necessarily performance enhancing, and they can also have reverse effects on performance (Mackey et 
al., 2012,#12).  
In line with Safai (2003) the study show that some athletes carefully consider situational aspects, for 
example, when it is appropriate to use analgesics (#8#,14,#15; Section 3.6.1-2). In addition, many athletes 
deliberately refrain from using analgesics or at least minimise their use (Sections 3.4; 3.6.1-3), for example, 
for reasons related to: trust in/feeling the body, side-effects, knowledge and social norms (Figure 4). This 
shows norms and attitudes towards a sport-related use of analgesics among some athletes and their sporting 
network (#9,#11,#14; Section 3.6.1-2). It also confirms the existence of a ‘culture of precaution’ interacting 
with the ‘culture of risk’ (Safai, 2003) or that absenteeism is also present (Mayer and Thiel, 2018).   
4.2 The social and cultural context of the use of analgesics: ‘One for the team’?  
Mayer and Thiel (2018) showed a higher preparedness among handball players compared with track-and-
field athletes for presenteeism at work, including a willingness to ‘play’ despite having to take painkillers. 
Broadly similar, the current study found that team-sport athletes were more likely to have used analgesics 
when injured to be able to: i) compete in an important match; ii) qualify for an important match/final; or 
iii) keep the position on the team or have the contract prolonged. An explanation might be found in the 
differences in how risk cultures manifest themselves in sporting disciplines (Schnell et al, 2014). The 
specific social and cultural context and the complex interactions and interdependencies will influence 
athletes’ responses to drug use (Section 1.2). These may be explained by differences in the organisation of 
work influencing the way athletes are socialised and their discourses and practices with regard to substance 
use (Ohl et al., 2015). Further, social norms and discourses on showing willingness as well as the 
expectation and pressures to use analgesics to compete when injured (Roderick, 2006) might be more 
prominent in team sports, in which the success of the team (other athletes, sports personnel and the club) 
may be dependent on an athlete’s ability to play matches.  
Further, the differences in injury risk patterns (Hägglund et al., 2016) and the higher prevalence of 
long-term injuries among the team-sport athletes surveyed (Table 1) may suggests increased vulnerability 
and exposure to concrete pressure situations for team-sport athletes.  
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4.3 The sport-related use of analgesics: A matter of gender?  
In line with Mayer and Thiel (2018), the results suggest that gender seldom plays a role in work-related 
presenteeism. However, some exceptions were identified, with female athletes from individual sports more 
likely than male individual athletes to have used analgesics to compete when injured in an important 
competition. While male team-sport athletes were more likely than female team-sport athletes to have 
taken analgesics to compete with an injury in situations related to ensuring sporting success or be available 
for an important match. Further, the interviews indicate some gender differences in male discourses on this 
topic (Section 3.6.2-3). However, the interview findings suggest that male and female athletes training in 
the same sporting environment share more similarities than differences in their approaches to the sport-
related uses of analgesics. Gender similarity in the internalisation of risk cultures and willingness to 
compete injured was expected (Mayer and Thiel, 2018; Mayer et al., 2018).  
An explanation for gender similarities might be found in the strong influence of sport socialisation 
processes through which both male and female athletes learn to have the ‘right attitude’ with regard to the 
normalisation of risk, living with pain and championing competing injured (Charlesworth and Young, 
2006). Gender-specific responses to analgesics may, however, manifest themselves in other areas since 
athletes’ responses to injury and pain may be a product of both sport and gender socialisation processes. 
While sport socialisation processes increase gender equality, gender socialisation processes reflect more 
traditional gender roles that can lead athletes to adapt different sense-making strategies about injury, pain 
and analgesics, for example how – or whether – they feel they should accept, display and understand injury 
(Charlesworth and Young, 2006).  
4.4 Normalisation: Just part of the routine in the sport? 
Although studies illustrate how analgesics are an integral part of the routine in sports (Roderick, 2006; 
Waddington and Roderick, 2002; Section 1.2), relatively few of the athletes surveyed agreed that this was 
part of the routine in their particular sport. One explanation for this could be that routines are normalised 
and thus scarcely perceptible. Awareness of whether the decision to use pain-relieving medicines is 
because it is just part of routine may be part of a neutralisation strategy or technique (Sykes and Matza, 
1957) or rationalised by athletes through other reasons (Figure 2) such as their use for reducing stress in 
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the body. Further, the use of analgesics is embedded as a routine, ritual or habit – or derives from 
expectations in some environments (Table 2; #6,#7,#15; Section 3.6.1-3). Tscholl and colleagues (2015) 
found an overuse of NSAIDs prior to all FIFA World Cup matches and suggested that players used these 
without injuries. In the current study, the in-competition use of analgesics to reduce or remove pain or 
forget small injuries seems routinized for some athletes (Section 3.6.2-3) while some acknowledged that 
such a routine worked more as “placebo” (#7). Further, the prophylactic use belongs in various ways to 
the rituals and ‘routines’, for example as a way of reducing bodily stress (Figure 2; Section 6.3.1-2) “just 
to be sure” (#6,#7) or to get the body warmed up (#2).  
4.5 No pain, no gain – or feeling and ignoring body pain?   
Pain and injuries are predictable and integral occupational risks in athletes’ working lives (Section 1-1.1). 
Although analgesics are key to pain management in sport (Hainline et al., 2017), some athletes hesitate to 
use them for reasons often related to the belief that the body can or should handle pain itself (Figure 4,Table 
2; Section 3.6.1). In this respect, some athletes prefer to be able to feel the pain, and so may train and 
compete when injured without taking analgesics (#3,#4,#9,#10). Similarly, for some athletes, refraining 
from (or minimising) the use of analgesics had to do with being able to feel and control the body and pain 
to avoid a breakdown (#3,#11,Figure 4). The notion of still being able to feel some pain and retain bodily 
control was also used, however, as a normalisation strategy to categorise ‘light’ analgesics as ‘harmless’ 
(Section 3.6.2). An explanation for athletes wishing to (still) feel bodily pain might be found in the 
predictability and normalisation of pain and injury in sport culture (Nixon, 1996; Charlesworth and Young, 
2006).  
4.6 Guidance on analgesics or self-administration of use?  
Different actors potentially play a role with regard to sport-related drug use (Section 1.2). The ways sports 
medicine clinicians interact are critical (Section 1.1). The results show that athletes often had several 
sources of guidance on the use of analgesics and that the roles of doctors, coaches/managers or 
physiotherapists varied between sports (Figure 5, #1,#16,#17, Section 3.6.1-2). Further, situational aspects 
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in interactions with sporting networks led to changes in practices around analgesics, for example with a 
new coach, a new team/employer or role model (Sections 3.6.1; 3.6.3).   
Although guidance from medical experts seems pivotal for reducing health risks, the precarious 
working environment and common norms of sport may counteract opportunities for health protection 
(Section 1.1-1.2). For example, an athlete was pressured by the coach to use analgesics, whose reasoning 
was that he was the best and should be a ‘good role model’ (#5). This confirms how, in some environments, 
using analgesics is considered a matter of showing the ‘right attitude’, and how athletes risk stigmatisation 
if not fulfilling these common sporting norms (Roderick, 2006). Broadly similar the example of the 
‘persuasive coach’ (Section 3.6.1) illustrates how common aspects of ‘sport ethics’ were used to convince 
hesitating athletes to use analgesics and supplements. In this case, the coach’s authority seemed pivotal in 
influencing norms and practices around non-therapeutic or prophylactic uses of analgesics in the 
environment. A recent report (Tingstad and Petersen, 2020) illustrates the pivotal role of certain former 
national coaches in enforcing sickness presenteeism on swimmers involving use of analgesics and reveals 
extreme working conditions with lack of care for the swimmers’ health and wellbeing.  
However, Murphy and Waddington (2007) argue for the notion of ‘risk transfer’, suggesting that 
responsibilities and risks are shared or transferred rather than athletes being victims or exploited by their 
environment. Study results often seem to support this notion with various forms of self-administration 
being examples of ‘risk transfers’. The finding that half of the athletes (also) self-administer analgesics 
and/or obtain knowledge and exchange experiences with other athletes confirm that athletes may treat their 
symptoms themselves (Malcolm, 2009) and act as ‘mini experts’ in the sporting environment (Roderick, 
2006). Athletes may search for knowledge and navigate through expert advice, like a male athlete (#18) 
who formulated his strategy as: “Listen to everyone: make up my own mind”. The self-administration of 
analgesics involves risks (Warden, 2009) and may be influenced by subcultural norms and traditions in the 
specific sporting environment. Broadly similar with other research (Malcolm, 2009; Pike, 2006) some 
athletes disregard medical advice or avoid consulting medical experts when it is anticipated they will 
recommend rest but self-medicate (Section 3.6.2). 
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5. Conclusion  
Applying a multi-dimensional mixed-method approach and exploring different questions about the sport-
related use of analgesics contributes to our understanding of the complexity of this issue in the working 
context of sport and adding to our knowledge of sickness presenteeism and absenteeism in elite sport. In 
conclusion, the sport-related use of analgesics is prevalent. Analgesics were integrated into the sporting 
routines and used for various reasons in- and out-of-competition and with and without injury. Most athletes 
had already used or would be willing to use analgesics to be able to train or compete when injuries may 
threaten their careers or sporting success. Simultaneously, many athletes refrained from using or sought to 
minimise their sport-related use of analgesics for reasons related to: trust in and feeling the body; worries 
about the physical and mental side-effects; their lack of knowledge about certain substances; and social 
norms. The study identified sport- and culture-specific patterns and gender similarities in their approaches 
to the uses of analgesics. Furthermore, it showed how interactions with sporting networks play a key role 
in influencing norms and practices in training environments, with athletes navigating in various ways 
through the advice given to them, through the requirements of their sporting network and through self-
administered use.  
An important study limitation is that the interviews only included elite athletes from individual sports 
(Section 2.1,3.6). The inclusion of team-sport athletes would have added further nuances to sport-specific 
issues, particularly to the in-competition use of analgesics when injured and on how team dynamics or the 
organisation of work may have an impact on the use of analgesics. Other limitations relate to sample 
heterogeneity (all high performance athletes from one single country) and reliance on self-reporting. 
Findings are not representative a specific sport. Further, the cross-sectional design does not allow for 
identification of potential changes in athletes’ sport-related use of analgesics over the course of their 
careers nor allow for observation of developments/changes within dynamic sporting environments. Future 
studies could apply a longitudinal mixed-method design to explore the complexity of sport-related use of 
analgesic, specific routines and issues within different sporting disciplines (in different countries) and 
circumstances/events influencing changes in presenteeism and absenteeism cultures. Further, studies could 
explore development/changes in use of analgesics and perceptions during an athlete’s career, considering 
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the impact of the organisation of work, of change in coaches/medical staff, of career- and health 
obstacles/events, and of transitioning into another working environment.   
 
 
Notes   
 
1:The Danish healthcare model is universal with free healthcare for all citizens. Hansen and Andersen 
(2008) suggested that the Danish welfare state – and its flexicurity model combining flexibility and 
security – might decrease sickness presenteeism.  
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† The percentages illustrated in the table are those of the 696 athletes replying to the survey questions on analgesics. The 
survey questions on analgesics were placed at the very end of the very long questionnaire, and athletes were free to skip 
the questions if they liked and withdraw from the survey. 79 of the 775 athletes decided not answer any of the questions 
on analgesics. Thus, participant characteristics of these athletes are not included in Table 1.  
   Note: Age range 13 to 46 years of age (3% below 16 years of age. 19% between 16 and 17 years old; 16% between 18-
19 years old; 22% 20-23 years old; 22% 24-29 years old, 16% 30-39 years old, 1% 40 years and older).  
‡ The numbers in parentheses refer to the percentage of athletes who had this experience more than once  
* Overtraining (like injuries) reduces the athlete’s work productivity (performance level) and can influence mental health. This 
condition may be linked to (sickness) presenteeism. This is because the overtraining syndrome (the medical condition) 
results from the athlete ignoring body signals of excessive fatigue, tiredness and stress over a long period of time and 
continuing to train regardless, without sufficient time to recover.  
Note: Further details about distribution of sports and categorisations - as well as interview guidelines and survey questions - 









 Table 1: Participants’ characteristics  
N=696† (N=775)  
 
 Sport type 
Team/ball 
sports 






          Total  Team sport  Individual sport 
Sport type  100% 47%  24% 17% 12% 
Gender 
Male 59% 57%  62% 63% 59% 
Female 41% 43%  38% 37% 41% 
Mean age (SD)  21.79 (5.60) 21.13 (5.03)  22.10 (5.80) 22.02 (5.28) 23.41 (7.26) 
Small injury‡ 93%(77%)   97%(84%)  92%(81%) 92%(70%) 82%(54%) 
 
A long-lasting injury (kept you from 




67%(36%) 57%(26%) 47%(15%) 
 





20%(8%) 8%(4%) 11%(2%) 
A longer period of time constantly ill 




45%(28%) 66%(50%) 41%(25%) 
Sick for a longer period of time (kept 
you from sport for  > 3 weeks)‡ 16%(5%) 14%(4%) 
 
14%(6%) 26%(7%) 14%(2%) 
Been in overtraining (e.g. longer period 
with excessive fatigue, heavy muscles, 
decreased performance, change in 
sleeping patterns and concentration)* 
63%(39%) 66%(41%) 
 
63%(41%) 63%(35%) 47%(28%) 
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Elaboration on the 
product or the 
frequency of use (9) 
#1: I have had painkillers on prescription from the doctor, e.g. Tramadol. These did not 
help, so I used painkillers although they did not help either (female, TS)  
Elaboration on 
situation (5) 
#2: Particularly in connection with games where knocks and similar things made it difficult 
to get the body warmed up (female, TS)  
Train or compete hurt, 
but not on pain-
relieving medicines (2) 
#3: I have trained despite having minor injuries but without painkillers because I believe 
that pain is the body’s way to tell you how it feels. When using painkillers, you are not 
aware of how bad it is – and I would like to feel this, so I can avoid more severe injuries 
(although I would play anyway) (male, TS) 
Change over time 
(less than earlier) (2) 
#4: I only use very few pain relievers now, but I did use a lot when I was younger. I prefer 
to feel when/that it hurts, so I can feel my limit. (female, MS) 
Pressure from coach 
(1) 
#5: I am being pressured by our national coach to play because I am the best and should 
be a role model for the others, he says (male, MS) 
Routine (1) 
#6: It is part of the routine in my sport, but not part of the routine in my club, where we 
normally are not allowed to play on pain-relieving medicines (male, TS) 
Habit (1) 
#7: Sometimes the placebo effect has an effect. That is, one takes pain-relieving 
medicines for small injuries before the game, and when the game has started, one 
"forgets" the pain. In such situations it probably would not have been necessary because 








#8: It depends 100% on the situation, e.g. what competition and how important it is 
(female, MS) 
 
Would never use (1) 
#9: I would never use pain relievers, I would just carry on playing without, and if the pain 










#10: It has seldom been so serious, and I have mostly just played with whatever there 
was in the way of injuries and then looked at it after the game or something (male, TS)  
Risk of worsening the 
situation (3) 
#11: It can create severe or chronic harm if one trains oneself to pieces without feeling it 
(female, ES) 
Negative effect on 
strength (2) 
#12: It is restrictive for building strength to use, for example ibuprofen. It reduces the 
effects of training and aggravates the damaged area (female, SP)  
When it feels right (2) 
#13: I only use painkillers if it feels like the right thing to do. But I have thought about it 
more lately since several football players have fallen over on the pitch (male, TS)  
Reduce long-term use 
(1) 
#14: Because I have used the substance over a long period of time, but felt that I should 
cut down (for health reasons) even though the pains were still present (male, ES) 
Systematic use 
despite knowledge of 
risks (1)  
#15: Risk of worsening the situation if one trains on pain relievers. But I take pain relievers 
after training, if necessary, during a period of injury to recover faster (but it seldom 




Family members with 
expert knowledge (6) 
#16: Doctors, nurses, dentists in family.  
 
Elaboration of other 
expert groups (8) 
#17: Pharmacy/pharmacist (5); chiropractor (2); Anti-doping Denmark/national team (1). 
Elaboration of self-
administering (6) 
#18: Example of strategies: Listen to everyone: make up my own mind (male, SP); read 
about it in magazines and other places (female, SP); read articles, etc. on the internet 




Figure 1: Athletes’ experience with sport-related use of pain-relieving products (n=688; 8 athletes did not 
know whether they had used painkillers). †Answer category in this item was: “one time” and “more than 

















































Figure 2: Reasons and circumstances for use of painkillers among athletes with experience of the sport-
related use of painkillers (n=631). Note: the proportion of athletes who train or compete despite injury, but 
without pain-relieving medicines, may be significantly higher. †175 of the athletes answered: “It is not like 












0% 10% 20% 30% 40% 50% 60% 70% 80% 90% 100%
To enhance performance level at competition/match
Because it is part of the routine in your sport †
To relieve headache
To relieve soreness
To reduce stress in body
To reduce inflammation
In connection with operation
To be able to train - despite an injury - during an
important training period
To be able to compete in an important
match/competition, although you were (or got) injured
To be able to train or compete - despite an injury -
because you felt it was nessessary to keep your
position on the team or have your contract prolonged
To be able to compete - despite an injury - because
you felt it was nessessary to qualify yourself or your
























































Figure 3: Use of – and willingness to use – analgesics in specific situations (n=696). The answers include 
both those from Q2 and the willingness (or lack thereof) by athletes who had used painkillers, but not in 
the specific situation (Q3a), and those who had never used painkillers in a sporting context (Q3b). Note: 
differences in percentages between those who have used analgesics in Figures 2 and 3 are because Q2 
only considers reasons among those who had used pain-relieving medicines (n=631) and Figure 3 displays 






































0% 10% 20% 30% 40% 50% 60% 70% 80% 90% 100%
If it becomes part of the routine in your sport †
To enhance performance level at competition/match
To be able to train or compete - despite an injury -
because you felt it was nessessary to keep your
position on the team or have your contract prolonged
To be able to train - despite an injury - during an
important training period
To be able to compete - despite an injury - because
you felt it was nessessary to qualify yourself or your
team for an important match or final
To be able to compete in an important

















































I do not know






Figure 4: Reasons for (consciously) having decided to refrain from or minimise the sport-related use of 


























0% 10% 20% 30% 40% 50% 60% 70% 80% 90%100%
It is not welcome/appropriate in my sporting
environment
I think it is cheating
I think it is wrong to use
My coach, doctor or physiotherapist thinks it is wrong
to use
I do not know enough about the product
I fear that it may contain prohibited substances
I worry about other side-effects
I worry about getting osteoarthritis when I get older
I worry about being physically or mentally dependent
on the substance
I think it would worsen the situation
I do not think it would improve the situation
I think the body should handle it




























































































I handle it myself I never receive











No guidance Other relations
